MedTrace Logo

Juvenile Inflammatory Rheumatism (JIR) Cohorte

NCT02377245 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2023-06-15

No results posted yet for this study

Summary

The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.

Conditions

  • Arthritis, Juvenile Rheumatoid

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER

  • Versailles Hospital

    collaborator OTHER

  • Tenon Hospital, Paris

    collaborator OTHER

  • Bicetre Hospital

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • University Hospital Muenster

    collaborator OTHER

  • Fondation Rhumatismes-Enfants-Suisse

    collaborator UNKNOWN

  • Michaël Hofer

    lead OTHER

Principal Investigators

  • Michael Hofer · University of Lausanne Hospitals

  • Véronique Hentgen · Versailles Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • Belgium
  • France
  • Germany
  • Morocco
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377245 on ClinicalTrials.gov